Adamas Pharmaceuticals Inc·4

Jun 7, 5:09 PM ET

LIEBERBURG IVAN M 4

4 · Adamas Pharmaceuticals Inc · Filed Jun 7, 2018

Insider Transaction Report

Form 4
Period: 2018-06-06
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-06-06+10,00010,000 total
    Exercise: $27.98Exp: 2028-06-05Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]The Option shares shall vest as follows: 100% of the option shares shall vest on the date 1 year from June 6, 2018, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION